Optimal timing of surgery in head and neck squamous cell carcinoma after neoadjuvant immunochemotherapy.

Front Oncol · 2026 · PMC12920233 · PMID 41727640

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

showed a trendp=0.087so close (0.05 < p ≤ 0.1)

Patients in the TTS 2-3 weeks group showed a trend toward higher complication risk (OR 1.35, p=0.087), and those in the TTS >3 weeks group had a significantly increased risk, with an odds ratio of 1.67 (95% CI: 1.11-2.14, p=0.021).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.